Pharmaceutical ProductCached Profile

ELLIPSYS VASCULAR ACCESS SYSTEM

Active Ingredients (Generic):Unmapped
Therapeutic Area: Catheters
LIFETIME PROMOTIONAL SPEND
$4,497,242
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

FDA Patient Safety Profile

Dynamic safety indicators compiled from official FDA product labels.

Active Clinical Trials

Clinical studies listing this drug as an active intervention.

Top Funded Physicians (Cumulative)

Doctors receiving the highest aggregate promotional support for this product.

Dr. STEPHEN PARKERMedical Doctor$669,719
Dr. JEFFREY HULLMedical Doctor$532,467
Dr. DALE YOUNGMedical Doctor$361,190
Dr. RISHI RAZDANMedical Doctor$246,593
Dr. DAVID SMIDMedical Doctor$242,932

Drug Marketing Payments Log

Federal registry records of promotional speaking, consulting, meals, and offsets.

Year:
2024
2024
2023
2022
2021

Querying Open Payments Database

Fetching live CMS.gov records for ELLIPSYS VASCULAR ACCESS SYSTEM...